Randall Bateman, MD

Washington University in St. Louis

Randall Bateman, MD is the Charles F. and Joanne Knight Distinguished Professor of Neurology. His research focuses on the pathophysiology and development of diagnostics and treatments of Alzheimer’s disease. His lab accomplishments include pioneering central nervous system Stable Isotope Labeling Kinetics (SILK) measurements in humans, furthering insights of human circadian patterns of amyloid-beta and soluble APP, and developing a blood test for brain amyloid plaques. Dr. Bateman directs the DIAN-TU, which launched the first prevention trial in families with early onset Alzheimer’s disease. The DIAN-TU trial is a global adaptive trial platform testing the most advanced therapeutics targeting Alzheimer’s disease.